MG
ELGX

Michael Gelband’s Endologix Inc ELGX Stock Holding History

Michael Gelband’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-40,000
Closed -$290K – 1791
2019
Q2 		$290K Buy
+40,000
New +$273K 0.01% 714

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.72B AUM 7.92% 1-Year Est. Return

Michael Gelband's ELGX Position: Q3 2019 in Review

Michael Gelband sold out of Endologix Inc (ELGX) in Q3 2019, closing a stake of 40,000 shares — an estimated $290K sold.

Michael Gelband first reported a position in ELGX in Q2 2019 and held it in 1 quarter. The position peaked at $290K in Q2 2019. 63 funds tracked by Wall St. Rank hold ELGX as of Q3 2019.

  • Michael Gelband reported no remaining Endologix Inc position as of Q3 2019 after selling out during the quarter.
  • Michael Gelband sold 40,000 Endologix Inc shares in Q3 2019, an estimated $290K.
  • Michael Gelband first reported a position in Endologix Inc in Q2 2019 and held it in 1 quarter.
  • Michael Gelband's Endologix Inc position peaked at $290K in Q2 2019.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2019.

Based on ExodusPoint Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.